YM BioSciences announced on August 10, 2009, that its wholly-owned subsidiary, YM BioSciences USA (YM-USA) received a license from the US Department of the Treasury’s Office of Foreign
As per the agreement, Novartis received an upfront fee and will receive royalties on net sales of Proleukin in the US. Novartis is also eligible to receive potential
Under the agreement, Envoy will use its proprietary bacTRAP technology to identify proteins expressed specifically in certain cell types. Merck will then work to identify and develop compounds
Graspa is a new enzyme formulation of L-asparaginase with a safer and broader range of clinical use’s, as compared to existing forms, due to the enzymes entrapment and
Huber needles are used to access ports implanted under the skin of chronically ill patients for repeated access to veins for the withdrawal of blood and infusion of
The company said that ATI-1123 has the same active ingredient as the FDA approved drug, Taxotere (docetaxel). The study is being conducted at two premier Texas cancer centers,
The therapeutic antibodies were generated by using a special cell line, Spymeg. Spymeg is the cell line established by the cell fusion of MEG-01 with a murine myeloma
Morphine Sulfate Oral Solution CII is indicated for the relief of moderate to severe acute and chronic pain where use of an opioid analgesic is appropriate. The company
The company expects to have available the 3.5g tube size in cartons of 24, Hospital –Pak, as well as the single 3.5g tube package size over the next
The companies said that the agreement includes patents relating to real-time polymerase chain reaction methods and instrumentation, including the 5’ Nuclease process and the use of SYBR Green
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.